Braxia Scientific Wants To Offer Ketamine Treatments In ‘Less Restrictive’ Environments. Will It Be Safe? Dec 1, 2021
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360… Dec 1, 2021
First-ever Human Data on SSRI – Psilocybin Interactive Effects Published by MindMed and Liechti Lab Nov 30, 2021
Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its… Nov 30, 2021
